Allergy diagnostics market seen reaching $13.03 billion by 2030

The global allergy diagnostics market is projected to grow from $6.99 billion in 2025 to $13.03 billion by 2030, fueled by rising allergy cases, broader testing use and advances in diagnostic technology. North America was the largest regional market in 2025, while demand is expected to expand across hospital, academic and diagnostic labs.

Why it matters: - The allergy diagnostics market is expanding as more patients need faster and more precise identification of triggers for food, drug and environmental allergies. - Growth in testing matters because accurate diagnosis helps clinicians recommend better treatment plans and allergy avoidance strategies. - The market outlook points to continued demand for in-vitro testing, point-of-care tools and more personalized allergy care.

What happened: - The Business Research Company released its Allergy Diagnostics Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market will rise from $6.99 billion in 2025 to $7.94 billion in 2026. - The report projects the market will reach $13.03 billion by 2030. - The forecast implies a 13.5% CAGR from 2025 to 2026 and a 13.2% CAGR through 2030. - North America was the largest regional market in 2025.

The details: - Rising allergy prevalence worldwide is a major growth driver. - Increased use of skin prick and intradermal tests is supporting near-term expansion. - Hospital-based laboratories are expanding, adding more testing capacity. - Limited availability of advanced in-vitro testing kits has helped sustain demand for existing testing methods. - The forecast period is expected to benefit from component-resolved diagnostics, greater automation in allergy testing and higher research spending on novel allergens. - Academic and diagnostic laboratories are expected to expand further. - Demand is rising for personalized allergy treatments. - Key trends include broader use of in-vitro testing, more testing for food and drug allergens, and wider use of ELISA, RAST and CRD kits. - Rapid and point-of-care allergy detection is also gaining attention. - Allergy diagnostics includes tests and procedures used to identify specific triggers such as foods, pollens and chemicals. - The main goal is to identify allergens accurately so healthcare professionals can plan treatment. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in addition to North America. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The market forecast reflects a shift from broad allergy testing toward more targeted diagnostics. - Automation and component-resolved testing suggest pressure for more standardized and precise results. - A September 2024 update from Anaphylaxis UK shows the real-world burden remains high: 20% of food allergy reactions happen in school settings. - The same update said one in five children with food allergies face bullying, and a similar share of parents report moderate to severe anxiety. - Nearly all parents of affected children show signs of post-traumatic stress symptoms, with higher rates among parents of children who use adrenaline auto-injectors. - Environmental pollution from traffic emissions and industrial activity is linked to the rising incidence of allergic diseases.

What's next: - Market growth is expected to continue through 2030 as laboratories expand and testing technology advances. - Broader use of in-vitro methods and point-of-care testing could reshape how allergies are diagnosed. - Demand is likely to stay strong for diagnostics tied to food and drug allergies, where precise identification can affect treatment decisions. - The report’s regional breakdown suggests future growth opportunities beyond North America as other regions build diagnostic capacity.

The bottom line: - Allergy diagnostics is moving from a niche testing category to a larger, more technology-driven healthcare market with global growth potential.